Alpha Tau Medical Ltd. (DRTS)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Biotechnology
Alpha Tau Medical Ltd.
NASDAQ:DRTSHealthcare · Biotechnology
-1.28%$13.06
AH$13.06+0.00%vs close
Mkt Cap$1.21B
Float63.91M
O/S92.48M
Vol
$ Vol
RVOL
Inst Own8.6%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$42.63M
Total Assets$106.58M
Free Cash Flow-$32.76M
Debt & Equity
Debt 15%
Equity 85%
Total Debt$13.73M
Total Equity$77.1M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in DRTS's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$106.58M
Liabilities$29.48M
Accounts Receivable$36K
Accounts Payable$3.87M
Inventory$0
PP&E (Net)$26.88M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - |
| Cost of Revenue | $1.23M | $0 | $0 | $0 | $0 | $86K | $0 |
| Gross Profit | -$1.23M | $0 | $0 | $0 | $0 | -$86K | $0 |
| Gross Margin | - | - | - | - | - | - | - |
| Research and Development | $30.83M | $27.02M | $26.42M | $20.89M | $11.45M | $7.46M | $6.64M |
| Selling, General, and Administrative | $10.22M | $9.02M | $9.26M | $11.25M | $2.34M | $1.7M | $1.37M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $41.06M | $36.04M | $35.68M | $32.14M | $13.79M | $9.16M | $8.01M |
| Operating Income (EBIT) | -$42.29M | -$36.04M | -$35.68M | -$32.14M | -$13.79M | -$9.24M | -$8.01M |
| Operating Margin | - | - | - | - | - | - | - |
| Interest Expense | $419K | $303K | $75K | $0 | $0 | $217K | $0 |
| Interest Income | $3.84M | $4.28M | $4.83M | $1.79M | $211K | $636K | $776K |
| Other Income (Expense) | -$218K | $4.3M | $6.54M | -$1.61M | -$13.47M | $520K | -$308K |
| Income Before Tax (EBT) | -$42.51M | -$31.74M | -$29.14M | -$33.74M | -$27.26M | -$8.72M | -$8.32M |
| Income Tax Expense | $121K | $6K | $16K | $20K | $7K | $158K | $146K |
| Net Income | -$42.63M | -$31.75M | -$29.16M | -$33.76M | -$27.27M | -$8.88M | -$8.46M |
| Net Income Margin | - | - | - | - | - | - | - |
| Supplementary Data | |||||||
| EPS | -0.53 | -0.45 | -0.42 | -0.53 | -0.40 | -0.13 | -0.13 |
| Diluted EPS | -0.53 | -0.45 | -0.42 | -0.53 | -0.40 | -0.13 | -0.13 |
| Weighted Average OS | 80.58M | 69.93M | 69.38M | 63.53M | 67.62M | 67.62M | 67.62M |
| EBITDA | -$41.06M | -$30.34M | -$27.99M | -$32.76M | -$26.49M | -$9.16M | -$7.94M |
| EBITDA Margin | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $15.98M | $13.72M | $12.66M | $5.84M | $23.24M | $15.6M | $1.83M |
| Short-Term Investments | $60.92M | $45.88M | $69.13M | $98.69M | $8.08M | $30.42M | $26.3M |
| Cash and Short-Term Investments | $76.9M | $59.6M | $81.79M | $104.53M | $31.32M | $46.02M | $28.13M |
| Accounts Receivable | $36K | $332K | $344K | $32K | $480K | $477K | $141K |
| Inventory | $0 | $0 | $0 | $0 | -$8.17M | $0 | $1.13M |
| Other Current Assets | $0 | $3.25M | $3.15M | $1.13M | $8.79M | $576K | -$187K |
| Total Current Assets | $78.3M | $64.23M | $85.76M | $106.48M | $32.64M | $47.45M | $29.83M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $26.88M | $21.54M | $21.16M | $13.28M | $7.55M | $5.39M | $1.71M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $928K | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $479K | $432K | $471K | $391K | $2.03M | $139K | $16K |
| Total Long-Term Assets | $28.28M | $21.98M | $21.63M | $13.67M | $9.57M | $5.53M | $1.73M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $106.58M | $86.2M | $107.39M | $120.15M | $42.22M | $52.99M | $31.56M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $3.87M | $3.53M | $2.57M | $1.42M | $1.2M | $964K | $893K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $3.78M | $1.52M | $1.16M | $1.34M | $2.41M | $599K | $0 |
| Total Current Liabilities | $10.51M | $8.68M | $7.1M | $4.34M | $4.41M | $2.09M | $1.35M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $6.35M | $5.56M | $5.61M | $0 | $53.96M | $53.96M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $1.02M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $5.35M | $3.34M | $3.6M | $5.63M | $18.62M | $5.37M | $30.4M |
| Total Long-Term Liabilities | $18.97M | $14.86M | $15.81M | $10.15M | $72.59M | $59.33M | $30.4M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $29.48M | $23.54M | $22.91M | $14.49M | $76.99M | $61.42M | $31.75M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $59K | $30K |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $690 | $0 |
| Retained Earnings | -$190.14M | -$147.51M | -$115.76M | -$86.6M | -$52.84M | -$25.57M | -$16.69M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | -$60K | -$21K |
| Other Stockholders' Equity | $267.24M | $210.18M | $200.23M | $192.26M | $18.06M | $17.14M | $16.49M |
| Total Equity | $77.1M | $62.67M | $84.47M | $105.66M | -$34.78M | -$8.43M | -$193K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $106.58M | $86.2M | $107.39M | $120.15M | $42.22M | $52.99M | $31.56M |
| Supplementary Data | |||||||
| Total Debt | $13.73M | $12.54M | $13.28M | $5.19M | $53.96M | $53.96M | $0 |
| Net Debt | -$2.25M | -$1.19M | $619K | -$643K | $30.73M | $38.37M | -$1.83M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$42.63M | -$31.75M | -$29.16M | -$33.76M | -$27.27M | -$8.88M | -$8.46M |
| Depreciation & Amortization | $1.23M | $1.1M | $1.07M | $979K | $776K | $86K | $66K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $994K |
| Stock-Based Compensation | $0 | $9.92M | $7.93M | $6.75M | $812K | $596K | $546K |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $337K | $965K | $1.14M | $220K | $239K | $114K | $148K |
| Other Working Capital | $1.95M | $203K | $1.35M | -$527K | $346K | $785K | -$212K |
| Total Working Capital Change | $2.29M | $1.17M | $2.49M | -$307K | $585K | $899K | -$64K |
| Other Non-Cash Items | $12.42M | -$219K | -$293K | $2.46M | $13.29M | $50K | $12K |
| Net Cash from Operating | -$26.68M | -$19.78M | -$17.96M | -$23.88M | -$11.81M | -$7.25M | -$6.91M |
| Investing Activities | |||||||
| Capital Expenditures | -$6.08M | -$2.24M | -$6.4M | -$904K | -$2.93M | -$3.77M | -$1.29M |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $9K |
| Purchases of Investments | -$70.49M | -$125.08M | $0 | $0 | $0 | $0 | -$54.27M |
| Sales of Investments | $55.98M | $148.19M | $0 | $0 | $0 | $0 | $45.4M |
| Other Investing Activities | $0 | -$103K | $25.08M | -$89.03M | $22.2M | -$4.05M | -$9K |
| Net Cash from Investing | -$20.59M | $20.77M | $18.68M | -$89.94M | $19.27M | -$7.82M | -$10.16M |
| Financing Activities | |||||||
| Debt Repaid | - | - | - | - | - | - | - |
| Common Stock Issuance | $45.77M | $25K | $49K | $3.36M | $111K | $29.32M | $5.25M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $5.25M | $93.54M | $0 | $0 | $73K |
| Net Cash from Financing | $45.77M | $25K | $5.3M | $96.91M | $111K | $29.32M | $5.32M |
| Forex Effect | $501K | $160K | $3.1M | -$258K | $108K | $1.93M | -$18K |
| Net Change in Cash | -$1M | $1.17M | $9.12M | -$17.17M | $7.68M | $16.17M | -$11.77M |
| Supplementary Data | |||||||
| Operating Cash Flow | -$26.68M | -$19.78M | -$17.96M | -$23.88M | -$11.81M | -$7.25M | -$6.91M |
| Capital Expenditure | -$6.08M | -$2.24M | -$6.4M | -$904K | -$2.93M | -$3.77M | -$1.29M |
| Free Cash Flow | -$32.76M | -$22.02M | -$24.36M | -$24.78M | -$14.74M | -$11.02M | -$8.2M |
| Cash at Beginning | $16.98M | $15.81M | $6.69M | $23.85M | $16.17M | $0 | $13.61M |
| Cash at End | $15.98M | $16.98M | $15.81M | $6.69M | $23.85M | $16.17M | $1.84M |